8-K
Current Report
Jasper Therapeutics, Inc. Filed Acc 0001213900-23-005155
Material agreement · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading ea172170-8k_jasper.htm…